KFF Brief Explains the Legal Challenges to New Title X Regulations
Attorneys General from 23 states, major family planning organizations, individual providers, and the American Medical Association have sued to block the new rules.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Attorneys General from 23 states, major family planning organizations, individual providers, and the American Medical Association have sued to block the new rules.
This report summarizes the major findings from KFF and HMA case studies in five U.S. communities, highlighting cross-cutting themes and the degree to which low-income women in diverse communities face challenges in accessing reproductive and sexual health care, as well as promising initiatives established by community providers to address barriers and improve access to these basic services.
This KFF analysis finds that the supplemental Title X funding that HHS awarded to grantees to “prioritize filling service gaps” in the federal family planning program still leaves significant gaps in many parts of the country.
This data note provides estimates of the status of the Title X network following the implementation of the new regulations.
Source Planned Parenthood Sites and Grantees Withdrawing from Title X Program If Court Does Not Block New Regulations…
This map details the Planned Parenthood sites and grantees that will withdraw from the Title X family planning program if the 9th Circuit Federal Court of Appeals does not block the Trump Administration’s new Title X regulations by August 19, 2019.
This tracker provides a listing of global health-related legislation introduced in the current Congress.
Intrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews the various IUDs approved by the FDA; awareness, use, and availability of IUDs; and key issues in insurance coverage and financing of IUDs in the United States.
This issue brief examines two possible scenarios and timelines for issuing new Title X regulations and distributing program funding to those grantees and sites that may seek to return to the Title X network if the abortion referral restrictions are lifted.
This report highlights key findings from the 2020 KFF National Physician Survey on Reproductive Health that asked a nationally representative sample of OBGYNs practicing in the United States about a wide range of issues, including their provision of contraception, abortion, and STI care.
© 2026 KFF